NEW YORK (GenomeWeb News) – Stem cell technology developer Cellular Dynamics International said today it has inked a collaborative agreement with the Hamner Institute to develop predictive in vitro screening assays to be used in toxicity testing and risk assessment.

The Research Triangle Park, NC-based firm said the human induced pluripotent stem cell assays will enable chemical, environmental, and pharmaceutical toxicology assessments without the use of animal models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.